BenevolentAI Employee Directory
Software DevelopmentEngland, United Kingdom51-200 Employees
BenevolentAI applies artificial intelligence to biomedicine to help systems read, reason about, and explain vast biomedical knowledge. Its aim is to augment scientists rather than substitute them, a point illustrated when its AI helped identify baricitinib as a potential Covid-19 treatment within 48 hours. The company offers Qor, a strategic decision intelligence platform designed for biotech leaders to harness AI-driven insights across the life sciences landscape. Headquartered in London, England, BenevolentAI was founded in 2013 and operates as a mid-sized software developer in the life sciences space. Its focus serves biotech and pharmaceutical organizations seeking faster, more informed drug discovery and decision making through AI-enabled interpretation of biomedical knowledge. In early 2024, the company appointed Dr. Joerg Moeller as chief executive officer and executive board member.